CIK 0000908259
- Non-accelerated filer
- Smaller reporting company
Oncotelic Therapeutics, Inc.
Sign in to watch- Ticker
- OTLC
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 133679168
- Phone
- +1 650-635-7000
- Business address
- 29397 AGOURA RD., #107, AGUORA HILLS, CA, 91301
- Former names
- MATEON THERAPEUTICS INC, OXIGENE INC
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Director bought 50,000 shares at an average $4.63 ($231,673)
- 4 Grant or award Chief Scientific Officer acquired 80,000 shares (grant or award)
- 4 Grant or award President and CEO acquired 80,000 shares (grant or award)
- 4 Grant or award Director acquired 80,000 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 40,000 shares (grant or award)
- 4 Grant or award Chief Operating Officer acquired 40,000 shares (grant or award)
- 4 Grant or award Director acquired 40,000 shares (grant or award)
- 4 Grant or award Director acquired 40,000 shares (grant or award)
- 4 Grant or award Director acquired 40,000 shares (grant or award)
- 4 Grant or award Director acquired 40,000 shares (grant or award)
- 4 Returned to the company Director returned 10,856 shares (to the company)
- 4 Open-market buy Director bought 4,000 shares at $4.75 ($19,000)
- 4 Open-market buy Director bought 1,000 shares at $4.51 ($4,510)
- 4 Open-market buy Director bought 101,600 shares at $4.52 ($459,232)
- 4 Open-market buy Director bought 15,000 shares at $4.48 ($67,200)
- 4 Open-market buy Director bought 25,000 shares at $4.37 ($109,250)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
Page 13 of 17 · 325 filings